III. Mechanism

  1. Selective IV Beta Blocker

V. Pharmacokinetics

  1. Half-Life: 9 minutes
    1. Rapidly metabolized by erythrocyte esterase
  2. Duration of action: 15-20 minutes

VI. Metabolism

  1. Renal Excretion
  2. Plasma levels are not affected by renal or hepatic dysfunction

VII. Dosing: Intravenous

  1. Preparation: 2.5 g (10 ml ampule) in 250 ml (10 mg/ml)
  2. Load: 250-500 mcg/kg over 1 min (70 kg: 35 mg, 3.5 ml)
  3. Infusion:
    1. Start 25-50 mcg/kg/min IV (70 kg: 10 ml/h provides 25 mcg/kg/min)
    2. Titrate up 25-50 mcg/kg every 5 to 10 min to max 300 mcg/kg/min

VIII. Safety

  1. Pregnancy Category C
  2. Unknown safety in Lactation

X. References

  1. Hamilton (2010) Tarascon Pharmacopoeia, Jones and Bartlett, Boston
  2. Pevtsov (2022) Esmolol, StatPearls, Treasure Island, FL (accessed 12/25/2022)
    1. https://www.ncbi.nlm.nih.gov/books/NBK518965/

Images: Related links to external sites (from Bing)

Related Studies

Ontology: esmolol (C0116569)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C036604
SnomedCT 372847006, 77856005
English esmolol, esmolol [Chemical/Ingredient], esmolol (medication), beta blockers esmolol, ESMOLOL, Esmolol, Esmolol (product), Esmolol (substance)
Spanish esmolol (producto), esmolol (sustancia), esmolol

Ontology: Brevibloc (C0591189)

Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C036604
English Brevibloc, Baxter brand of esmolol hydrochloride, Boots brand of esmolol hydrochloride, Prasfarma brand of esmolol hydrochloride, Rhône-Poulenc Rorer brand of esmolol hydrochloride

Ontology: Esmolol hydrochloride (C0700606)

Definition (NCI) The hydrochloride salt form of esmolol, a short and rapid-acting beta adrenergic antagonist belonging to the class II anti-arrhythmic drugs and devoid of intrinsic sympathomimetic activity. Esmolol hydrochloride competitively blocks beta-1 adrenergic receptors in cardiac muscle and reduces the contractility and cardiac rate of heart muscle, thereby decreasing cardiac output and myocardial oxygen demands. This agent also decreases sympathetic output centrally and blocks renin secretion. At higher doses, esmolol hydrochloride also blocks beta-2 receptors located in bronchial and vascular smooth muscle, thereby leading to smooth muscle relaxation.
Concepts Pharmacologic Substance (T121) , Organic Chemical (T109)
MSH C036604
SnomedCT 35318005, 318624002
English 4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzenepropanoic Acid Methyl Ester HCl, (+-)-Methyl p-(2-hydroxy-3-(isopropylamino)propoxy)hydrocinnamate Hydrochloride, Esmolol Hydrochloride, esmolol hydrochloride (medication), ESMOLOL HYDROCHLORIDE, esmolol HCl, Esmolol hydrochloride, Esmolol hydrochloride product, Esmolol hydrochloride (substance), Esmolol hydrochloride product (product), Esmolol hydrochloride product (substance), esmolol hydrochloride
Spanish producto con clorhidrato de esmolol (producto), clorhidrato de esmolol (producto), producto con clorhidrato de esmolol, clorhidrato de esmolol (sustancia), clorhidrato de esmolol, producto (producto), clorhidrato de esmolol, producto, clorhidrato de esmolol